coccidioidomycosis
Showing 1 - 11 of 11
Invasive Candidiasis, Mucocutaneous Candidiasis, Coccidioidomycosis Trial in Worldwide (Ibrexafungerp)
Active, not recruiting
- Invasive Candidiasis
- +9 more
-
Birmingham, Alabama
- +36 more
Jan 25, 2023
Genetics of Disseminated or Refractory Coccidioidomycosis
Recruiting
- Coccidioidomycosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Coccidioidomycosis Trial in San Antonio (Placebo, VT-1598)
Completed
- Coccidioidomycosis
- Placebo
- VT-1598
-
San Antonio, TexasICON Early Phase Services Clinical Research Unit
Dec 15, 2022
Coccidioidomycosis, Valley Fever Trial in Sacramento (SUBA-itraconazole)
Withdrawn
- Coccidioidomycosis
- Valley Fever
-
Sacramento, CaliforniaUniversity of California, Davis Medical Center
Jul 13, 2021
Valley Fever, Coccidioidomycosis Trial in Tucson (Cholesterol-containing moisturizers)
Terminated
- Valley Fever
- Coccidioidomycosis
- Cholesterol-containing moisturizers
-
Tucson, Arizona
- +1 more
Jun 1, 2021
Coccidioidomycosis in Patients Receiving Anti-TNF and Other
Completed
- Coccidioidomycosis
- Rheumatoid Arthritis
-
Tucson, ArizonaUniversity of Arizona - Arizona Arthritis Center
Dec 11, 2015
Coccidioidomycosis Trial in United States (Spherule-derived coccidioidin)
Completed
- Coccidioidomycosis
- Spherule-derived coccidioidin
-
Tucson, Arizona
- +3 more
Oct 28, 2013
Coccidioidomycosis Trial in Tucson (nikkomycin Z)
Terminated
- Coccidioidomycosis
- nikkomycin Z
-
Tucson, ArizonaClinical & Translational Research Center - University of Arizona
Feb 12, 2013